Profile | GDS4284 / 202301_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2941.54 | 88 |
GSM687648 | Patient 402 control | 2552.81 | 87 |
GSM687653 | Patient 403 control | 3228.13 | 89 |
GSM687658 | Patient 404 control | 2122.39 | 85 |
GSM687663 | Patient 411 control | 3045.57 | 89 |
GSM687668 | Patient 422 control | 3356.26 | 90 |
GSM687673 | Patient 424 control | 3182.01 | 89 |
GSM687678 | Patient 425 control | 2387.46 | 86 |
GSM687683 | Patient 427 control | 2370.28 | 86 |
GSM687688 | Patient 428 control | 2812.41 | 88 |
GSM687695 | Patient 441 control | 1566.76 | 82 |
GSM687699 | Patient 443 control | 2177.14 | 85 |
GSM687704 | Patient 444 control | 2241.29 | 85 |
GSM687707 | Patient 448 control | 4528.23 | 93 |
GSM687712 | Patient 449 control | 2764.7 | 88 |
GSM687719 | Patient 450 control | 2124.82 | 85 |
GSM687724 | Patient 451 control | 3374.1 | 90 |
GSM687728 | Patient 452 control | 2723.35 | 88 |
GSM687646 | Patient 401 treated 24h | 3105.7 | 89 |
GSM687649 | Patient 402 treated 24h | 2616.62 | 87 |
GSM687665 | Patient 411 treated 24h | 2638.02 | 87 |
GSM687651 | Patient 402 treated 4 weeks | 2707.42 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2839.67 | 88 |
GSM687670 | Patient 422 treated 24h | 3414.22 | 90 |
GSM687671 | Patient 422 treated 4 weeks | 3829.79 | 91 |
GSM687654 | Patient 403 treated 24h | 2884.15 | 88 |
GSM687675 | Patient 424 treated 24h | 3033.27 | 89 |
GSM687685 | Patient 427 treated 24h | 2940.07 | 88 |
GSM687656 | Patient 403 treated 4 weeks | 3363.54 | 90 |
GSM687677 | Patient 424 treated 4 weeks | 2633.64 | 87 |
GSM687687 | Patient 427 treated 4 weeks | 3350.39 | 90 |
GSM687692 | Patient 428 treated 4h | 2498.64 | 87 |
GSM687716 | Patient 449 treated 4h | 2631.92 | 87 |
GSM687722 | Patient 450 treated 4h | 1820.98 | 83 |
GSM687680 | Patient 425 treated 24h | 2024.33 | 84 |
GSM687690 | Patient 428 treated 24h | 2335.42 | 86 |
GSM687700 | Patient 443 treated 24h | 1896.54 | 84 |
GSM687705 | Patient 444 treated 24h | 2352.15 | 86 |
GSM687714 | Patient 449 treated 24h | 2805.04 | 88 |
GSM687721 | Patient 450 treated 24h | 1964.68 | 84 |
GSM687682 | Patient 425 treated 4 weeks | 1618.05 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 2336.68 | 86 |
GSM687702 | Patient 443 treated 4 weeks | 2409.88 | 86 |
GSM687718 | Patient 449 treated 4 weeks | 2912.93 | 89 |
GSM687723 | Patient 450 treated 4 weeks | 2197.88 | 85 |
GSM687661 | Patient 404 treated 4h | 2733.83 | 88 |
GSM687710 | Patient 448 treated 4h | 4355.89 | 92 |
GSM687726 | Patient 451 treated 4h | 3339.74 | 90 |
GSM687730 | Patient 452 treated 4h | 1975.75 | 85 |
GSM687660 | Patient 404 treated 24h | 1880.56 | 85 |
GSM687697 | Patient 441 treated 24h | 2186.16 | 86 |
GSM687709 | Patient 448 treated 24h | 4597.28 | 93 |
GSM687725 | Patient 451 treated 24h | 3221.37 | 90 |
GSM687729 | Patient 452 treated 24h | 2587.84 | 88 |
GSM687727 | Patient 451 treated 4 weeks | 3765.58 | 91 |
GSM687731 | Patient 452 treated 4 weeks | 2620.15 | 87 |